08/04/2026
Placebo:
Part 4: insights for clinical trials and clinical practice
BACKGROUND:
🔎Placebo and nocebo effects are psychobiological responses triggered by the context of treatment rather than the treatment itself. Increasing recognition that these effects are driven by mechanisms such as expectations, learning, and contextual cues.
DEFINITIONS:
📝Placebo and nocebo are defined as positive and negative health outcomes resulting from expectations, context, and meaning attributed to treatment, respectively.
📍A recent scoping review by Bagnis et al. (2025) mapped existing evidence on placebo and nocebo responses and their mechanisms, to identify implications for trials and healthcare.
CLINICAL TRIALS
👨🔬Clinical trials must be controlled and measured to ensure validity.
📈Placebo and nocebo effects can inflate or obscure true treatment effects, and increase variability in outcomes. Nocebo may lead to high drop outs or misattribution of adverse events
📝Recommendations: careful trial design with standardisation of participant information and measurement of expectations and contextual factors.
CLINICAL PRACTICE
👩⚕️Clinical practice must be leveraged to improve outcomes and minimised to reduce harm through effective communication and therapeutic context.
📈Clinicians can ethically harness placebo effects through positive but realistic framing of treatment benefits, while building a strong therapeutic alliance.
📉Strategies to minimise nocebo effects include balanced risk-benefit analysis, and the use of reassuring, non-alarmist language.
SUMMARY:
📖Placebo and nocebo effects are powerful, measurable, and clinically relevant phenomena. They arise from expectations, learning, and contextual cues, with identifiable neurobiological pathways.
📚In clinical trials, they must be controlled and measured to ensure validity. Whereas, in clinical practice, they can be leveraged to improve outcomes and minimised to reduce harm through effective communication and therapeutic context.
MW
Reference:
Bagnis A, Meeuwis SH, Haas JW, O’Keeffe M, Bajcar EA, Babel P, Evers AWM, Glogan E, … and on behalf of the PANACEA Consortium. A scoping review of placebo and nocebo responses and effects: insights for clinical trials and practice. Health Psychology Review,2025;19(2):409-447.